BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 20816013)

  • 1. Influence of oleic acid on the rheology and in vitro release of lumiracoxib from poloxamer gels.
    Moreira TS; de Sousa VP; Pierre MB
    J Pharm Pharm Sci; 2010; 13(2):286-302. PubMed ID: 20816013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel transdermal delivery system for the anti-inflammatory lumiracoxib: influence of oleic acid on in vitro percutaneous absorption and in vivo potential cutaneous irritation.
    Moreira TS; de Sousa VP; Pierre MB
    AAPS PharmSciTech; 2010 Jun; 11(2):621-9. PubMed ID: 20373151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and characterisation of modified poloxamer 407 thermoresponsive depot systems containing cubosomes.
    Kojarunchitt T; Hook S; Rizwan S; Rades T; Baldursdottir S
    Int J Pharm; 2011 Apr; 408(1-2):20-6. PubMed ID: 21272624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced transdermal delivery of ketoprofen from bioadhesive gels.
    Singh S; Gajra B; Rawat M; Muthu MS
    Pak J Pharm Sci; 2009 Apr; 22(2):193-8. PubMed ID: 19339232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics of poloxamer thermosensitive in situ gel of dexamethasone sodium phosphate].
    Li XY; Zhu ZJ; Cheng AY
    Yao Xue Xue Bao; 2008 Feb; 43(2):208-13. PubMed ID: 18507351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheological characterization of Poloxamer 407 lidocaine hydrochloride gels.
    Ricci EJ; Bentley MV; Farah M; Bretas RE; Marchetti JM
    Eur J Pharm Sci; 2002 Nov; 17(3):161-7. PubMed ID: 12393144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular poloxamer-based ciprofloxacin hydrochloride in situ forming gels.
    Mansour M; Mansour S; Mortada ND; Abd Elhady SS
    Drug Dev Ind Pharm; 2008 Jul; 34(7):744-52. PubMed ID: 18612913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: Design, characterisation, toxicity and transcorneal permeation studies.
    M A Fathalla Z; Vangala A; Longman M; Khaled KA; Hussein AK; El-Garhy OH; Alany RG
    Eur J Pharm Biopharm; 2017 May; 114():119-134. PubMed ID: 28126392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified thermoresponsive Poloxamer 407 and chitosan sol-gels as potential sustained-release vaccine delivery systems.
    Kojarunchitt T; Baldursdottir S; Dong YD; Boyd BJ; Rades T; Hook S
    Eur J Pharm Biopharm; 2015 Jan; 89():74-81. PubMed ID: 25481034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and evaluation of novel controlled release of topical pluronic lecithin organogel of mefenamic acid.
    Jhawat V; Gupta S; Saini V
    Drug Deliv; 2016 Nov; 23(9):3573-3581. PubMed ID: 27494650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of gelation process and drug release profile of thermosensitive liquid lecithin/poloxamer 407 based gels as carriers for percutaneous delivery of ibuprofen.
    Djekic L; Krajisnik D; Martinovic M; Djordjevic D; Primorac M
    Int J Pharm; 2015 Jul; 490(1-2):180-9. PubMed ID: 26002567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium alginate in oil-poloxamer organogels for intravaginal drug delivery: Influence on structural parameters, drug release mechanisms, cytotoxicity and in vitro antifungal activity.
    Querobino SM; de Faria NC; Vigato AA; da Silva BGM; Machado IP; Costa MS; Costa FN; de Araujo DR; Alberto-Silva C
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():1350-1361. PubMed ID: 30889669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of carrageenan on poloxamer-based in situ gel for vaginal use: Improved in vitro and in vivo sustained-release properties.
    Liu Y; Zhu YY; Wei G; Lu WY
    Eur J Pharm Sci; 2009 Jun; 37(3-4):306-12. PubMed ID: 19491020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and in vitro evaluation of a pluronic lecithin organogel containing ricinoleic acid for transdermal delivery.
    Boddu SH; Bonam SP; Wei Y; Alexander K
    Int J Pharm Compd; 2014; 18(3):256-61. PubMed ID: 25306775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermoresponsive fluconazole gels for topical delivery: rheological and mechanical properties, in vitro drug release and anti-fungal efficacy.
    Gandra SC; Nguyen S; Nazzal S; Alayoubi A; Jung R; Nesamony J
    Pharm Dev Technol; 2015 Jan; 20(1):41-9. PubMed ID: 24160864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of lecithin on some physical chemical properties of poloxamer gels: rheological, microscopic and in vitro permeation studies.
    Bentley MV; Marchetti JM; Ricardo N; Ali-Abi Z; Collett JH
    Int J Pharm; 1999 Dec; 193(1):49-55. PubMed ID: 10581421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, rheological study, and characterization of an organogel as a system for transdermal release of active principles.
    Ruiz MA; Clares B; Morales ME; Gallardo V
    Pharm Dev Technol; 2007; 12(6):637-44. PubMed ID: 18161637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization and evaluation of thermoresponsive diclofenac sodium ophthalmic in situ gels.
    Asasutjarit R; Thanasanchokpibull S; Fuongfuchat A; Veeranondha S
    Int J Pharm; 2011 Jun; 411(1-2):128-35. PubMed ID: 21459137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temperature-responsive, Pluronic-g-poly(acrylic acid) copolymers in situ gels for ophthalmic drug delivery: rheology, in vitro drug release, and in vivo resident property.
    Ma WD; Xu H; Nie SF; Pan WS
    Drug Dev Ind Pharm; 2008 Mar; 34(3):258-66. PubMed ID: 18363141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of a ricinoleic acid poloxamer gel system for transdermal eyelid delivery.
    Boddu SH; Bonam SP; Jung R
    Drug Dev Ind Pharm; 2015 Apr; 41(4):605-12. PubMed ID: 24517574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.